IMTX logo

Immatics NV (IMTX) Company Overview

Profile

Full Name:

Immatics N.V.

Sector:

Healthcare

Industry:

Biotechnology

Country:

Germany

IPO:

December 12, 2018

Indexes:

Not included

Description:

Immatics NV is a biotechnology company focused on developing innovative cancer immunotherapies. They use advanced technology to create treatments that harness the body’s immune system to target and destroy cancer cells, aiming to improve outcomes for patients with various types of cancer.

Key Details

Price

$4.36

Annual Revenue

$58.46 M(-67.93% YoY)

Annual EPS

-$1.30(-323.98% YoY)

Annual ROE

-43.99%

Beta

0.79

Events Calendar

Earnings

Next earnings date:

Mar 21, 2025

Recent quarterly earnings:

Nov 18, 2024

Recent annual earnings:

Mar 21, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

Nov 19, 24 B of A Securities
Buy
Oct 7, 24 Piper Sandler
Overweight
Sep 9, 24 Cantor Fitzgerald
Overweight
Sep 5, 24 Cantor Fitzgerald
Overweight
May 16, 24 Mizuho
Buy
Nov 2, 23 Cantor Fitzgerald
Overweight
Mar 31, 23 Mizuho
Buy
Mar 23, 23 Chardan Capital
Buy
Aug 10, 22 Chardan Capital
Buy
Jun 3, 22 SVB Leerink
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Immatics NV?
  • Does Immatics NV pay dividends?
  • What sector is Immatics NV in?
  • What industry is Immatics NV in?
  • What country is Immatics NV based in?
  • When did Immatics NV go public?
  • Is Immatics NV in the S&P 500?
  • Is Immatics NV in the NASDAQ 100?
  • Is Immatics NV in the Dow Jones?
  • When was Immatics NV's last earnings report?
  • When does Immatics NV report earnings?

What is the ticker symbol for Immatics NV?

The ticker symbol for Immatics NV is NASDAQ:IMTX

Does Immatics NV pay dividends?

No, Immatics NV does not pay dividends

What sector is Immatics NV in?

Immatics NV is in the Healthcare sector

What industry is Immatics NV in?

Immatics NV is in the Biotechnology industry

What country is Immatics NV based in?

Immatics NV is headquartered in Germany

When did Immatics NV go public?

Immatics NV's initial public offering (IPO) was on December 12, 2018

Is Immatics NV in the S&P 500?

No, Immatics NV is not included in the S&P 500 index

Is Immatics NV in the NASDAQ 100?

No, Immatics NV is not included in the NASDAQ 100 index

Is Immatics NV in the Dow Jones?

No, Immatics NV is not included in the Dow Jones index

When was Immatics NV's last earnings report?

Immatics NV's most recent earnings report was on Nov 18, 2024

When does Immatics NV report earnings?

The next expected earnings date for Immatics NV is Mar 21, 2025